Question 1

What is the DPP® technology?

Accepted Answer

The DPP® (Dual Path Platform) technology is a proprietary platform developed by the company that enables rapid, accurate, and easy-to-use diagnostic tests. It allows for the simultaneous detection of multiple analytes from a single sample, providing more comprehensive results.

Question 2

Does the company offer any self-test products?

Accepted Answer

Yes, the company offers the Sure Check® HIV Self-Test, which allows users to test themselves for HIV in the privacy of their own home.

Question 3

What certifications or approvals do the company's products have?

Accepted Answer

The company's products have received various certifications and approvals, including FDA clearance, CLIA waiver, and CE marking. For example, the DPP® HIV-Syphilis assay is the first and only FDA-approved test that can screen for both HIV and syphilis from a single sample.

Question 4

Where does the company operate globally?

Accepted Answer

Chembio Diagnostics, the parent company, has operations in the United States, as well as global subsidiaries and partnerships in countries like Brazil, Nigeria, and Malaysia. The company's products are available in various markets around the world.

Chembio Diagnostics Systems Inc

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

Established

About Chembio Diagnostics Systems Inc

Frequently Asked Questions about Chembio Diagnostics Systems Inc

What is the DPP® technology?

Does the company offer any self-test products?

What certifications or approvals do the company's products have?

Where does the company operate globally?

Technologies Used

Social Profiles

Key Decision Makers